| acc4351 |
Rac1 |
nitration |
Tyr32 |
mouse |
Acute Lung Injury |
|
NipR2 (nitration inhibitor peptide for the Rho GTPases 2) |
Unresolved |
4.0 |
33248422
|
| acc4352 |
Akt |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4353 |
ERK |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4354 |
IRS1 |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4355 |
JNK |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4356 |
MAPK |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4357 |
p38 MAPK |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4358 |
PI3K |
phosphorylation |
unclear |
mouse |
Obesity |
|
CTFV |
Unresolved |
4.0 |
33273564
|
| acc4359 |
GluR1 |
phosphorylation |
unclear |
mouse |
Alzheimer's Disease |
|
Photobiomodulation (PBM) |
Unresolved |
3.0 |
33336891
|
| acc4360 |
JNK3 |
phosphorylation |
unclear |
mouse |
Alzheimer's Disease |
|
Photobiomodulation (PBM) |
Unresolved |
3.0 |
33336891
|
| acc4361 |
ERK1 |
phosphorylation |
Thr202 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4362 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4363 |
ERK2 |
phosphorylation |
Thr185 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4364 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4365 |
JNK |
phosphorylation |
Thr183 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4366 |
JNK |
phosphorylation |
Tyr185 |
human |
Cervical Cancer |
HeLa |
SP-FA |
Unresolved |
4.0 |
33357846
|
| acc4367 |
ERK |
phosphorylation |
Thr202 |
rat |
Colonic Hypersensitivity |
|
Linaclotide |
Unresolved |
4.0 |
33373484
|
| acc4368 |
ERK |
phosphorylation |
Tyr204 |
rat |
Colonic Hypersensitivity |
|
Linaclotide |
Unresolved |
4.0 |
33373484
|
| acc4369 |
ERK |
phosphorylation |
Thr185 |
rat |
Colonic Hypersensitivity |
|
Linaclotide |
Unresolved |
4.0 |
33373484
|
| acc4370 |
ERK |
phosphorylation |
Tyr187 |
rat |
Colonic Hypersensitivity |
|
Linaclotide |
Unresolved |
4.0 |
33373484
|
| acc4371 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4372 |
ERK1 |
phosphorylation |
Thr202 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4373 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4374 |
ERK2 |
phosphorylation |
Thr185 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4375 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4376 |
S6 |
phosphorylation |
Ser240 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4377 |
S6 |
phosphorylation |
Ser244 |
human |
Pancreatic Cancer |
MIAPaCa-2 |
CUDC-907 |
Negative |
5.0 |
33392641
|
| acc4378 |
PGC1alpha |
acetylation |
Lys |
rat |
Cardiac and Neurological Injuries |
H9c2 |
Ginsenoside Rc |
Unresolved |
4.0 |
33439015
|
| acc4379 |
PGC1alpha |
acetylation |
Lys |
rat |
Cardiac and Neurological Injuries |
PC12 |
Ginsenoside Rc |
Unresolved |
4.0 |
33439015
|
| acc4380 |
IkappaBalpha |
phosphorylation |
Ser32 |
mouse |
Colitis |
|
Coptisine |
Unresolved |
4.0 |
33508280
|
| acc4381 |
IkappaBalpha |
phosphorylation |
Ser36 |
mouse |
Colitis |
|
Coptisine |
Unresolved |
4.0 |
33508280
|
| acc4382 |
HSP27 |
phosphorylation |
Ser85 |
rat |
Cerebral Ischemia |
Wistar rat |
Geranylgeranylacetone |
Unresolved |
4.0 |
33557752
|
| acc4383 |
HMGB1 |
acetylation |
Lys12 |
rat |
Hyperoxic Lung Injury |
|
KYC |
Unresolved |
4.0 |
33607217
|
| acc4384 |
MPO |
oxidation |
unclear |
rat |
Hyperoxic Lung Injury |
|
KYC |
Unresolved |
4.0 |
33607217
|
| acc4385 |
Keap1 |
S-glutathionylation |
unclear |
rat |
Hyperoxic Lung Injury |
|
KYC |
Unresolved |
4.0 |
33607217
|
| acc4386 |
HMGB1 |
thiylation |
unclear |
rat |
Hyperoxic Lung Injury |
|
KYC |
Unresolved |
4.0 |
33607217
|
| acc4387 |
Keap1 |
thiylation |
unclear |
rat |
Hyperoxic Lung Injury |
|
KYC |
Unresolved |
4.0 |
33607217
|
| acc4388 |
EGFR |
phosphorylation |
Tyr1173 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4389 |
EGFR |
phosphorylation |
Tyr1173 |
rat |
Renal Fibrosis |
NRK-44F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4390 |
NF-kappaB p65 |
phosphorylation |
Ser536 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4391 |
NF-kappaB p65 |
phosphorylation |
Ser536 |
rat |
Renal Fibrosis |
NRK-49F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4392 |
Smad3 |
phosphorylation |
Ser423 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4393 |
Smad3 |
phosphorylation |
Ser425 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4394 |
Smad3 |
phosphorylation |
Ser423 |
rat |
Renal Fibrosis |
NRK-46F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4395 |
Smad3 |
phosphorylation |
Ser425 |
rat |
Renal Fibrosis |
NRK-47F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4396 |
Src |
phosphorylation |
Tyr416 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4397 |
Src |
phosphorylation |
Tyr416 |
rat |
Renal Fibrosis |
NRK-45F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4398 |
STAT3 |
phosphorylation |
Tyr705 |
mouse |
Renal Fibrosis |
|
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4399 |
STAT3 |
phosphorylation |
Tyr705 |
rat |
Renal Fibrosis |
NRK-48F |
Nintedanib + Gefitinib |
Unresolved |
4.0 |
33614732
|
| acc4400 |
STAT3 |
acetylation |
Lys685 |
rat |
Ocular Hypertension |
|
SNC-121 |
Unresolved |
4.0 |
33628191
|
